Nicotinamide
- Generic Name
- Nicotinamide
- Brand Names
- Alertonic, Fortaplex, Infuvite, Infuvite Pediatric, Mvc-fluoride, Mvi Pediatric, Natafort, Neo-bex, Nicomide, Pregvit, Tandem Plus
- Drug Type
- Small Molecule
- Chemical Formula
- C6H6N2O
- CAS Number
- 98-92-0
- Unique Ingredient Identifier
- 25X51I8RD4
- Background
An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.
- Indication
用于防治糙皮病等烟酸缺乏病，也用于防治心脏传导阻滞。
- Associated Conditions
- Gastrointestinal insufficiency, Hepatic Insufficiency, Macrocytic anemia, Secondary anemia, Vitamin Deficiency, Severe debilitation
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation, Dietary supplementation
Effect of Nicotinamide in Friedreich's Ataxia
- First Posted Date
- 2012-05-02
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 40
- Registration Number
- NCT01589809
- Locations
- 🇬🇧
National Hospital for Neurology and Neurosurgery, London, United Kingdom
🇬🇧NIHR/Wellcome Trust Imperial CRF, London, Hammersmith, United Kingdom
Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation
- Conditions
- Interventions
- First Posted Date
- 2012-03-02
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- Universidad Autonoma de San Luis Potosí
- Target Recruit Count
- 28
- Registration Number
- NCT01542138
- Locations
- 🇲🇽
Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosi, Mexico
Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
- Conditions
- Interventions
- First Posted Date
- 2010-09-14
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 252
- Registration Number
- NCT01200784
Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
- Conditions
- Interventions
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2016-05-16
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Target Recruit Count
- 176
- Registration Number
- NCT01011699
- Locations
- 🇫🇷
ALURAD, Limoges, Limousin, France
🇫🇷Centre Hospital-Universitaire d'Amiens, Amiens, Picardie, France
🇫🇷Centre Hospitalier, Cambrai, France
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
- Conditions
- Interventions
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 40
- Registration Number
- NCT00691210
- Locations
- 🇺🇸
Center for Lymphoid Malignancies at CUMC, New York, New York, United States
Safety Study of Nicotinamide to Treat Alzheimer's Disease
- Conditions
- Interventions
- First Posted Date
- 2007-12-27
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 50
- Registration Number
- NCT00580931
- Locations
- 🇺🇸
UC Irvine School of Medicine, Irvine, California, United States
The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2007-07-30
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 17
- Registration Number
- NCT00508885
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
- Conditions
- First Posted Date
- 2006-04-20
- Last Posted Date
- 2009-01-16
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT00316472
- Locations
- 🇺🇸
Washington University Medical Center, Saint Louis, Missouri, United States
Treatment of Acute Schizophrenia With Vitamin Therapy
- Conditions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Beersheva Mental Health Center
- Target Recruit Count
- 55
- Registration Number
- NCT00140166
- Locations
- 🇮🇱
Beersheva Mental Health Center, Beersheva, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.